English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, October 25, 2024
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024
Monday, September 16, 2024
君聖泰醫藥亮相香港國際生物科技論壇
Tuesday, September 17, 2024
君聖泰醫藥亮相香港國際生物科技論壇
Friday, September 13, 2024
君圣泰医药亮相香港国际生物科技论坛
Wednesday, September 11, 2024
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱(HTD1801)在T2DM中的两项事后分析
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
EASD 2024 | 君聖泰醫藥口頭報告熊去氧膽小檗碱(HTD1801)在T2DM中的兩項事後分析
Monday, August 12, 2024
2024 CSE - 君聖泰醫藥分享天然產物在代謝性疾病的創新成果
2024 CSE | 君圣泰医药分享天然产物在代谢性疾病的创新成果
Monday, July 1, 2024
河套科創區攜手13家創新企業 君聖泰醫藥協助創新藥國際化發展

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575